Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limiting.
Fisher
R I
RI
D018033:Antibodies, Bispecific / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D017730:Ki-1 Antigen / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology*; D016896:Treatment Outcome
D018033:Antibodies, Bispecific; D000911:Antibodies, Monoclonal; D017730:Ki-1 Antigen; D017452:Receptors, IgG